[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2004089387A1 - Use of the extraction process to obtain extract, sap, tincture, pulp and by-products from 'dicksonia sellowiana' - presl - hooker 1844 , for using at the human, industrial and pharmacological chemistry, human and animal, medicinal, phytomedicinal, nutriceutric. - Google Patents

Use of the extraction process to obtain extract, sap, tincture, pulp and by-products from 'dicksonia sellowiana' - presl - hooker 1844 , for using at the human, industrial and pharmacological chemistry, human and animal, medicinal, phytomedicinal, nutriceutric. Download PDF

Info

Publication number
WO2004089387A1
WO2004089387A1 PCT/BR2004/000043 BR2004000043W WO2004089387A1 WO 2004089387 A1 WO2004089387 A1 WO 2004089387A1 BR 2004000043 W BR2004000043 W BR 2004000043W WO 2004089387 A1 WO2004089387 A1 WO 2004089387A1
Authority
WO
WIPO (PCT)
Prior art keywords
pulp
sap
chemical
extract
sellowiana
Prior art date
Application number
PCT/BR2004/000043
Other languages
English (en)
French (fr)
Inventor
Elzo Ferreira
Original Assignee
Elzo Ferreira
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elzo Ferreira filed Critical Elzo Ferreira
Publication of WO2004089387A1 publication Critical patent/WO2004089387A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)

Definitions

  • the invention object of this patent is an absolutely new and not formerly disclosed scientific discovery in the world of the human and veterinary medicine; its purpose is to bring to light the medicinal, nutritional, mineral and vitamin-related properties of Xaxim - Dicksonia sellowiana-Presl-Hooker 1884 of the Dicksoniaceae family, through the process to obtain the extract, the essence, the tincture and the pulp, as well as the active principle (s) pertaining thereto, whether separated or not, extracted from the leaves, stem, pulp and/or root of the xaxim, xaxim bugio plant - Dicksonia sellowiana of the Dicksoniaceae family - Presl - Hooker 1844.
  • the active principle may be prepared in many different consistencies: liquid, aqueous, gelatinous, creamy, as an ointment, semi-solid, solid, food, nutriceutic, vapor (a changed state of matter), and powder, without losing its medical properties.
  • the extract contains different variations of certain chemical elements according to the PH of the soil where the plant was collected. However, said variations have not caused any loss of effectiveness, as evidenced by confidential scientific tests and experiments on volunteers who were willing to participate in the project development. No loss of efficacy was observed.
  • the extract and/or its by-products, used as a whole or in separate parts, as an active principle, or a compound or separate active principle, is used to treat cancer and obstructive diseases of the respiratory system, of a chronic or general nature - caused by viruses or bacteria. This led us to firmly believe that ours is the newest scientific discovery in a worldwide level, in the field of human and veterinary medicine .
  • Products derived from X ⁇ xim - Dicksonia sellowiana-Presl-Hooker 1844 may be liquid, gelatinous, semi-solid, solid, powdered and gaseous. Presentation modalities: syrups, tablets, injections, ointments, creams and in the gelatinous, liquid and semi-fluid form. Purposes: therapeutic, pharmacological, allopathic, homeopathic, phototherapeutic, as beverages, juices, nutritional/alimentary substances, vitamins, minerals, dermatological products, cosmetics, and veterinary applications in general, and also industrial chemistry and reversion engineering purposes.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cosmetics (AREA)
PCT/BR2004/000043 2003-04-09 2004-03-29 Use of the extraction process to obtain extract, sap, tincture, pulp and by-products from 'dicksonia sellowiana' - presl - hooker 1844 , for using at the human, industrial and pharmacological chemistry, human and animal, medicinal, phytomedicinal, nutriceutric. WO2004089387A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BR0301799A BR0301799A (pt) 2003-04-09 2003-04-09 Uso do processo de extração do extrato, da seiva, da tintura, da massa e dos produtos deles derivados, originários da planta xaxim - dicksonia sellowiana - presl - hooker 1844 pertencente à famìlia das dicksoniaceae para emprego nas seguintes áreas e setores: quìmica humana, industrial, farmacológica, biologia humana e animal, medicinal, fitomedicinal, fitoterápica, alopata, alimentìcia, nutricêutico, vitamìnico, dermatológica, cosmética e veterinária
BRPI0301799-0 2003-04-09

Publications (1)

Publication Number Publication Date
WO2004089387A1 true WO2004089387A1 (en) 2004-10-21

Family

ID=33136634

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2004/000043 WO2004089387A1 (en) 2003-04-09 2004-03-29 Use of the extraction process to obtain extract, sap, tincture, pulp and by-products from 'dicksonia sellowiana' - presl - hooker 1844 , for using at the human, industrial and pharmacological chemistry, human and animal, medicinal, phytomedicinal, nutriceutric.

Country Status (2)

Country Link
BR (1) BR0301799A (pt)
WO (1) WO2004089387A1 (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9090569B2 (en) 2004-11-18 2015-07-28 Synta Pharmaceuticals Corp. Triazone compounds that modulate HSP90 activity

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995019328A1 (de) * 1994-01-18 1995-07-20 Allplant Entwicklungs- Und Marketing Gmbh Kultursubstrat und verfahren zu dessen herstellung

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995019328A1 (de) * 1994-01-18 1995-07-20 Allplant Entwicklungs- Und Marketing Gmbh Kultursubstrat und verfahren zu dessen herstellung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SIMAN S E ET AL: "Fern spore extracts can damage DNA", BR J. CANCER, vol. 83, no. 1, July 2000 (2000-07-01), pages 69 - 73 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9090569B2 (en) 2004-11-18 2015-07-28 Synta Pharmaceuticals Corp. Triazone compounds that modulate HSP90 activity

Also Published As

Publication number Publication date
BR0301799A (pt) 2005-03-22

Similar Documents

Publication Publication Date Title
Manvitha et al. Aloe vera: a wonder plant its history, cultivation and medicinal uses
Harisaranraj et al. Evaluation of the Chemical Composition Rauwolfia serpentina and Ephedra vulgaris
CN104258193A (zh) 一种治疗神经衰弱和预防老年痴呆症的药物组合物
de Souza Ribeiro et al. An evaluative review on Stryphnodendron adstringens extract composition: Current and future perspectives on extraction and application
CN101875648B (zh) 一种从药用植物中提取纯化球松素的方法及其药物制剂与应用
Anjum et al. In vitro antioxidant and thrombolytic activities of Bridelia species growing in Bangladesh
CN101254217B (zh) 一种红豆杉树可再生部分的提取物的制备方法及该提取物在制备口服抗癌药物中的应用
CN103584098A (zh) 玛咖杏仁片及其制备方法
CN107198170A (zh) 一种天然树莓复合口服液的制备配方
JP2007284398A (ja) 皮膚外用組成物の製造方法
RU2332866C2 (ru) Биологически активная добавка к пище "перстевит"
WO2004089387A1 (en) Use of the extraction process to obtain extract, sap, tincture, pulp and by-products from 'dicksonia sellowiana' - presl - hooker 1844 , for using at the human, industrial and pharmacological chemistry, human and animal, medicinal, phytomedicinal, nutriceutric.
CN102631700A (zh) 纳米红豆杉系列保健日化卫生用品及其制作方法
RU2710261C1 (ru) Способ комплексной переработки свежих плодов боярышника мягковатого
KR20160010909A (ko) 양구 방산백토 추출 화이트이온미네랄(sy2220)과 화이트이온미네랄 증류수(sy2216)를 이용한 아토피, 여드름, 건선, 지루성 피부 개선용 미용비누 제조 방법 및 그 조성물
CN104255954B (zh) 一种黄蜀葵复方基础籽油及其制备方法和应用
KR101531850B1 (ko) 고려 홍삼과 천연식물 유용성분 및 천연 미네랄 염을 포함하는 조성물 및 그 제조방법
RU2402344C1 (ru) СПОСОБ ПОЛУЧЕНИЯ ФИТОПРЕПАРАТОВ ИЗ НЕКОТОРЫХ ВИДОВ КОПЕЕЧНИКА (КОПЕЕЧНИК ЧАЙНЫЙ - Hedysarum theinum, КОПЕЕЧНИК ЗАБЫТЫЙ - Hedysarum neglectum)
Garmashov et al. Technological parameters of countercurrent extraction: deriving bioactive compounds from plant raw materials
RU2452242C1 (ru) Способ получения биологически активной пищевой добавки
KR20150033896A (ko) 광물성 유황에 함유된 독성 제거 후 순수 유황 추출방법과 이를 활용하는 방법.
CN107362223B (zh) 一种含有鹿角帽胶的中药组合物及其制备方法与应用
CN106974996B (zh) 一种紫玉淮山提取物及其制备方法和应用
CN105192207A (zh) 一种辣木茶袋
RU2637414C1 (ru) Способ получения средства, обладающего противовоспалительной активностью

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTHING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC (EPO FORM 1205A DATED 28.02.2006

122 Ep: pct application non-entry in european phase